Stay updated on Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The revision label was updated from v3.5.2 to v3.5.3, signaling a small release update without modifying the study details.
    Difference
    0.1%
    Check dated 2026-04-30T18:13:51.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:28:06.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Site revision label updated from v3.4.3 to v3.5.0. This appears to be a minor version update with no substantive changes to the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-03-25T20:16:31.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    - Added a Resources entry linking to the Genetic and Rare Diseases Information Center for Malignant Pleural Mesothelioma.
    Difference
    0.2%
    Check dated 2026-03-18T13:47:53.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T11:16:28.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Site update adds Revision: v3.4.2 and removes the prior funding notice and Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T01:40:50.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.